Impact of serological and PCR testing requirements on the selection of COVID‐19 convalescent plasma donors

BACKGROUND: Convalescent plasma is undergoing randomized trials as a potential therapeutic option for COVID‐19 infection. Little empirical evidence exists regarding the determination of donor eligibility and experiences with donor selection. STUDY DESIGN AND METHODS: This prospective study was condu...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Transfusion
Autores principales: Carter, Jason A., Freedenberg, Alex T., Romeiser, Jamie L., Talbot, Lillian R., Browne, Nicholas J., Cosgrove, Megan E., Shevik, Margaret E., Generale, Laura M., Rago, Molly G., Caravella, Giuseppina A., Ahmed, Tahmeena, Mamone, Linda J., Bennett‐Guerrero, Elliott
Formato: Artigo
Lenguaje:Inglês
Publicado: John Wiley & Sons, Inc. 2021
Materias:
Blood Donors and Blood Collection
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC8013201/
https://ncbi.nlm.nih.gov/pubmed/33559248
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/trf.16293
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares